2020
DOI: 10.1080/14787210.2020.1759418
|View full text |Cite
|
Sign up to set email alerts
|

How can we improve uptake of oral HIV pre-exposure prophylaxis for transgender individuals?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 49 publications
0
6
0
Order By: Relevance
“…With regard to HIV treatment, specific antiretroviral medications may impact hormone concentrations; however, these can be managed by selecting alternative agents, monitoring and adjusting hormone dosing, or both (Cirrincione et al., 2020 ) as detailed in guidelines from the US Department of Health and Human Services (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2019 ). Nevertheless, concerns about drug-drug interactions, particularly interactions that may limit hormone concentrations, represent a barrier to the implementation and adherence to antiretroviral therapy for HIV prevention or treatment (Radix et al., 2020 ; Sevelius et al., 2016 ). Therefore, it is advisable for HCPs to proactively address such concerns with those who are candidates for PrEP or HIV treatment.…”
Section: Chapter 17 Sexual Healthmentioning
confidence: 99%
“…With regard to HIV treatment, specific antiretroviral medications may impact hormone concentrations; however, these can be managed by selecting alternative agents, monitoring and adjusting hormone dosing, or both (Cirrincione et al., 2020 ) as detailed in guidelines from the US Department of Health and Human Services (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2019 ). Nevertheless, concerns about drug-drug interactions, particularly interactions that may limit hormone concentrations, represent a barrier to the implementation and adherence to antiretroviral therapy for HIV prevention or treatment (Radix et al., 2020 ; Sevelius et al., 2016 ). Therefore, it is advisable for HCPs to proactively address such concerns with those who are candidates for PrEP or HIV treatment.…”
Section: Chapter 17 Sexual Healthmentioning
confidence: 99%
“…14,26,[29][30][31][32][33][34][35][36] Previous studies also suggest that gender-related stigma and discrimination, and early PrEP marketing campaigns that predominantly targeted sexual minority men are likely contributing factors to the observed lag in uptake of PrEP among TGW of color. 14,37,38 Socioecological frameworks posit that individuals exist withing larger systems (e.g., microsystem, mesosystem, exosystem, and macrosystem) and these higher level systems directly influence individual behavior. 39 Consistent with findings from previous studies, 40,41 we previously found barriers to PrEP uptake and persistence that spanned multiple individual, interpersonal, community, and structural socioecological levels among Black and Latinx TGW.…”
Section: Introductionmentioning
confidence: 99%
“…Very few trans people have accessed PrEP in Scotland (12). International studies suggest that the need for PrEP among this group is high but important barriers to access preclude uptake (36,43). Restricting PrEP provision to sexual health clinics probably deters some trans people who could benefit (44).…”
Section: Discussionmentioning
confidence: 99%